What Act set the requirements for child-resistant closures for prescription drugs, non-prescription drugs, and hazardous household products?

The Poison Prevention Packaging Act established the requirements for child-resistant closures for various categories of products, including prescription drugs, non-prescription drugs, and hazardous household products. The motivation behind this legislation was to prevent accidental poisonings among children, recognizing that certain medications and household substances can pose significant risks if ingested by young children.

This Act mandated that such products be packaged in a way that is difficult for children under five years old to open, without being overly cumbersome for adults. The implementation of child-resistant packaging has played a critical role in reducing the number of accidental poisonings and enhances the safety of common household items.

The other acts mentioned, while significant in their own right, do not specifically address the requirements for child-resistant closures. The Food, Drug, and Cosmetic Act primarily concerns the regulation of food and drugs, the Controlled Substances Act focuses on the classification and regulation of narcotics and substances, and the Kefauver-Harris Amendment addressed issues related to drug efficacy and safety but did not cover child-resistant packaging.